Transdigm (TDG) Tops Q4 EPS by 19c
Get Alerts TDG Hot Sheet
Join SI Premium – FREE
Transdigm (NYSE: TDG) reported Q4 EPS of $2.21, $0.19 better than the analyst estimate of $2.02. Revenue for the quarter came in at $642.2 million versus the consensus estimate of $631.54 million.
Transdigm sees FY2014 EPS of $8.03-$8.29, versus the consensus of $7.58. Transdigm sees FY2014 revenue of $2.51-2.55 billion, versus the consensus of $2.36 billion.
For earnings history and earnings-related data on Transdigm (TDG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Stardust Power (SDST) Tops Q2 EPS by 1c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share